Veru Inc Ár/Könyv
Mi az Veru Inc Ár/Könyv?
A Ár/Könyv az Veru Inc - 23.71
Mi a Ár/Könyv meghatározása?
Az ár-könyv arány aránya a vállalat részvényértéke és az egy részvényre jutó könyv szerinti érték arányát jelenti.
The price to book ratio, or P/B ratio, is a financial ratio used to compare a company's current market price to its book value. It is also sometimes known as a market to book ratio or price to equity ratio. The calculation of a price to book ratio can be performed in two ways. It can be calculated as the company's market capitalization divided by the company's total book value from its balance sheet. It can also be calculated using per-share values and dividing a company's current share price by the book value per share (i.e. its book value divided by the number of outstanding shares).
The P/B ratio varies between industries. The industries that require more infrastructure capital (for each dollar of profit) will usually trade at P/B ratios much lower than, for example, consulting firms. P/B ratios are commonly used to compare banks, because most assets and liabilities of banks are constantly valued at market values. A higher P/B ratio implies that investors expect management to create more value from a given set of assets, all else equal (and/or that the market value of the firm's assets is significantly higher than their accounting value).
P/B ratios do not, however, directly provide any information on the ability of the firm to generate profits or cash for shareholders. This ratio also gives some idea of whether an investor is paying too much for what would be left if the company went bankrupt immediately. For companies in distress, the book value is usually calculated without the intangible assets that would have no resale value. In such cases, P/B should also be calculated on a "diluted" basis, because stock options may well vest on sale of the company or change of control or firing of management.
Ár/Könyv a Health Care szektor a NASDAQ-on cégekben a Veru Inc -hoz képest
Mit csinál Veru Inc?
the female health company/veru healthcare is a therapeutics company focused on developing and commercializing pharmaceuticals and devices in men’s and women’s health and oncology. to realize this goal, veru healthcare has three divisions: pharmaceutical and devices, consumer health products, and public sector. for men, product and product candidates are in the areas of benign prostatic hyperplasia, male infertility, amelioration of side effects of hormonal prostate cancer therapies, prostate cancer, gout, and sexual dysfunction. women’s health has product candidates for female sexual health and advanced breast and ovarian cancers and markets fc2, a disposable contraceptive device, to ob gyn physicians and is the only female condom approved by fda that offers dual protection against sexually transmitted infections, including hiv/aids and the zika virus, and unintended pregnancy. since the female health company began distributing fc2 in 2007, the product has been shipped to 144 countries
ár/könyv -hoz hasonló cégek Veru Inc
- GT Biopharma nak Ár/Könyv 23.51 van
- GlobalData Plc nak Ár/Könyv 23.54 van
- Big Rock Partners Acquisition nak Ár/Könyv 23.54 van
- Vivakor nak Ár/Könyv 23.57 van
- Hambro Perks Acquisition nak Ár/Könyv 23.64 van
- Daido nak Ár/Könyv 23.65 van
- Veru Inc nak Ár/Könyv 23.71 van
- Cub nak Ár/Könyv 23.72 van
- Avricore Health nak Ár/Könyv 23.72 van
- Automatic Data Processing nak Ár/Könyv 23.72 van
- Tsakos Navigation nak Ár/Könyv 23.75 van
- Inphi nak Ár/Könyv 23.82 van
- Novo Nordisk nak Ár/Könyv 23.97 van